Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Dementia Discovery Fund
AddedFeb 15, 2024
UpdatedJun 28, 2026
Dementia Discovery Fund

Dementia Discovery Fund

Operating

World's largest venture fund specializing in dementia therapeutics, leveraging global partnerships for impactful, profitable investments.

Location
London, Greater London, GB
Founded
2015
Firm
Compare
Portfolio
Fundraising
Employees
Website

The Dementia Discovery Fund (DDF) is the world's largest specialized venture capital fund focusing exclusively on novel therapeutics for dementia, including Alzheimer's Disease. Managed by SV Health Investors, DDF has raised over $500 million to invest in companies addressing this significant unmet medical need. With offices in London and Boston, the fund capitalizes on global investment opportunities across various stages, from seed to later rounds.

DDF's portfolio includes notable companies such as Alector, Cerevance, and QurAlis. The fund's investment strategy targets innovative approaches to dementia treatment, leveraging its expertise and global partnerships to support portfolio companies. DDF's unique focus and substantial resources position it as a key player in advancing dementia therapeutics and potentially transforming patient outcomes in this critical field.

Dementia Discovery Fund - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments18
Current Portfolio Count7
Total Portfolio Exits0

Top Investment Stages

Series A6 (37.5%)
Seed4 (25.0%)
Series B3 (18.8%)
Series Unknown2 (12.5%)
Seed Extension1 (6.3%)

Stage Mix

Series A 38%Seed 25%Series B 19%Series Unknown 13%Seed Extension 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Violet Therapeutics logo

Violet Therapeutics

Therini Bio logo

Therini Bio

QurAlis logo

QurAlis

Cerevance logo

Cerevance

Nitrase Therapeutics logo

Nitrase Therapeutics

Ribometrix logo

Ribometrix

Alector logo

Alector

Dementia Discovery Fund - Similar Investment Firms

LSP Dementia Fund logo

LSP Dementia Fund

lspvc.com

ALS Investment Fund logo

ALS Investment Fund

Inbio Ventures logo

Inbio Ventures

Longevity Vision Fund logo

Longevity Vision Fund

longevity.vision

Pathway to Cures logo

Pathway to Cures

pathwaytocures.org

Brain Trust Accelerator Fund logo

Brain Trust Accelerator Fund

braintrustvc.com

DaVita Venture Group logo

DaVita Venture Group

NeuroVentures Capital logo

NeuroVentures Capital

neuroventures.com

CureDuchenne Ventures logo

CureDuchenne Ventures

cureduchenne.org

DigitalDx Ventures logo

DigitalDx Ventures

digitaldx.com

Green D Ventures logo

Green D Ventures

The Longevity Fund logo

The Longevity Fund

longevity.vc

Alchimia Investments logo

Alchimia Investments

Neo Kuma Ventures logo

Neo Kuma Ventures

neokuma.co

Denali Ventures logo

Denali Ventures

Dementia Discovery Fund - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end